Interestingly, the increased expression of MX1 autoantibody in serum is associated with a good prognosis in patients with idiopathic interstitial pneumonia [32], suggesting that the inhibition of MX proteins is a possible strategy for preventing fibrotic lung diseases. Here, MX1 is linked to idiopathic interstitial pneumonia.